fleroxacin has been researched along with Liver Dysfunction in 1 studies
Fleroxacin: A broad-spectrum antimicrobial fluoroquinolone. The drug strongly inhibits the DNA-supercoiling activity of DNA GYRASE.
fleroxacin : A fluoroquinolone antibiotic that is 4-oxo-1,4-dihydroquinoline which is substituted at positions 1, 3, 6, 7 and 8 by 2-fluoroethyl, carboxy, fluoro, 4-methylpiperazin-1-yl and fluoro groups, respectively. It is active against many Gram-positive and Gram-negative bacteria.
Excerpt | Relevance | Reference |
---|---|---|
"Fleroxacin is a new broad-spectrum quinolone which can be given by the oral route." | 1.29 | Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients. ( Cerruti, F; Herrmann, M; Hirschel, B; Leemann, T; Lew, DP; Portmann, R; Schrenzel, J; Weidekamm, E, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Schrenzel, J | 1 |
Cerruti, F | 1 |
Herrmann, M | 1 |
Leemann, T | 1 |
Weidekamm, E | 1 |
Portmann, R | 1 |
Hirschel, B | 1 |
Lew, DP | 1 |
1 other study available for fleroxacin and Liver Dysfunction
Article | Year |
---|---|
Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aged, 80 and over; Bacteremia; Female; Fleroxacin; H | 1994 |